Craniopharyngioma CT

Revision as of 16:01, 11 September 2012 by Prashanthsaddala (talk | contribs)
Jump to navigation Jump to search

Craniopharyngioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Craniopharyngioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Craniopharyngioma CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Craniopharyngioma CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Craniopharyngioma CT

CDC on Craniopharyngioma CT

Craniopharyngioma CT in the news

Blogs on Craniopharyngioma CT

Directions to Hospitals Treating Craniopharyngioma

Risk calculators and risk factors for Craniopharyngioma CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

CT

  • Cranial magnetic resonance imaging (MRI): An MRI uses magnetic fields but it is a different type of image than what is produced by computed tomography (CT). It can produce very detailed images of the brain to help diagnose craniopharyngioma. Like computed tomography (CT), a contrast agent may be injected into a patient’s vein to create a better picture.
  • Cranial computed tomography (CT) scan: CT scans are also used to diagnose craniopharyngioma. It can confirm the location of the tumor and show the organs nearby.
  • Endocrine hormone tests
  • Adamantinomatous-type tumor appears as a predominately cystic mass with a solid component (>90%).
  • The solid component appears isoattenuating and usually contains calcifications (>80%).
  • The sella may be expansile
  • Hydrocephalus may be present
  • Contrast enhancement is characteristic of the solid component and cyst wall (90% cases)
  • Papillary type is usually solid, isoattenuating, and rarely calcified.

References


Template:WikiDoc Sources